CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 231 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,000 | 0.0% | 62 | -29.5% | 0.00% | – |
| Q2 2022 | $2,000 | -33.3% | 88 | -31.2% | 0.00% | – |
| Q1 2022 | $3,000 | +200.0% | 128 | +172.3% | 0.00% | – |
| Q3 2021 | $1,000 | -66.7% | 47 | -59.1% | 0.00% | – |
| Q2 2021 | $3,000 | +50.0% | 115 | +11.7% | 0.00% | – |
| Q1 2021 | $2,000 | – | 103 | +442.1% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 19 | -99.8% | 0.00% | -100.0% |
| Q3 2020 | $159,000 | – | 9,186 | +61140.0% | 0.01% | – |
| Q2 2020 | $0 | -100.0% | 15 | -97.5% | 0.00% | -100.0% |
| Q4 2018 | $8,000 | +14.3% | 610 | +30.6% | 0.00% | 0.0% |
| Q3 2018 | $7,000 | -100.0% | 467 | -68.1% | 0.00% | -50.0% |
| Q2 2018 | $22,998,000 | +69590.9% | 1,463 | -26.4% | 0.00% | -33.3% |
| Q1 2018 | $33,000 | -23.3% | 1,987 | -17.6% | 0.00% | -25.0% |
| Q4 2017 | $43,000 | +152.9% | 2,411 | +172.1% | 0.00% | +100.0% |
| Q3 2017 | $17,000 | +750.0% | 886 | +430.5% | 0.00% | – |
| Q2 2017 | $2,000 | 0.0% | 167 | +21.9% | 0.00% | – |
| Q1 2017 | $2,000 | – | 137 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |